Study Detail

TitleEmergence of resistance to tyrosine kinase inhibitors in non-small cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib
Study TypeOther
Abstract Targeted exome sequencing of crizotinib-sensitive control cell line (H2228-CS) and crizotinib-resistant cell lines (H2228-CR).
Description Targeted exome sequencing of crizotinib-sensitive control cell line (H2228-CS) and crizotinib-resistant cell lines (H2228-CR).
Center NameAstex Pharmaceuticals